Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseasesNathan A. Berger, Csaba Szabó, Robert S. B. Clark et al.|British Journal of Pharmacology|2017Cited by 210
Cutting Edge: IL-1α Is a Crucial Danger Signal Triggering Acute Myocardial Inflammation during Myocardial InfarctionJérôme Lugrin, Lucas Liaudet|The Journal of Immunology|2014Cited by 111
Table of ContentsCaroline Olt, Kathleen Faulkenberg, Eileen Hsich et al.|The Journal of Heart and Lung Transplantation|2021Cited by 0